Gyan Srivastava

Associate Director & Head Of Computational Biology Alexion Pharma UK

Seminars

Thursday 5th February 2026
AI / Advanced Computing for New Target Discovery for AD/PD or Protein Aggregation Disorders in CNS
2:00 pm
  • Exploring the development of novel CRISPR-based screening approaches to identify new targets
  • Highlighting the need to improve the disease modelling systems to better reflect the progression of the disease, and improve upon the current models which are limited in their ability to capture the full complexity of the pathological processes
Gyan Srivastava, Associate Director & Head Of Computational Biology, Alexion Pharma UK - 14th Alzheimer's & Parkinson's Drug Development Summit